Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of May 2026
Laura Hermes @Laura Hermes
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Qualitative fundamental analysis

Market capitalization:

$8,159,441talents

Virtual portfolio value:

$5,061,204talents

Net overall return per annum:

18.95%

AYA current rank order:

#4

Asset investment philosophy:
Laura Hermes trades U.S. stocks with the top #51 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 51,225 +2,108.33% $388,798
HAO Haoxi Health Technology Limited Class A Ordinary Shares $0.15 $2.50 86,720 +1,566.67% $203,792
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 4,471 +589.24% $183,624
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 119,533 +793.33% $142,244
NTZ Natuzzi S.p.A. $2.21 $11.92 14,103 +439.37% $136,940
VATE INNOVATE Corp. Common Stock $0.53 $4.14 33,830 +681.13% $122,126
BQ Boqii Holding Limited American Depositary Shares representing Class A Ordinary Shares $0.36 $3.36 36,133 +833.33% $108,399
BQ Boqii Holding Limited Class A Ordinary Shares $0.36 $3.36 36,133 +833.33% $108,399
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 801 +601.88% $89,624
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 2,526 +660.87% $57,593
Sum $1,541,539

Top 10 current stock portfolio positions as of May 2026Strategy

Symbol Company Price Position Capitalization
ETON Eton Pharmaceuticals Inc. Common Stock $28.90 2,255 $65,169
VEEV Veeva Systems Inc. Class A Common Stock $171.60 348 $59,716
MGNI Magnite Inc. Common Stock $13.72 4,243 $58,213
LIF Life360 Inc. Common Stock $45.75 1,262 $57,736
LUMN Lumen Technologies Inc. Common Stock $9.32 6,153 $57,345
ALDX Aldeyra Therapeutics Inc. Common Stock $1.59 35,789 $56,904
DFH Dream Finders Homes Inc. Class A Common Stock $15.26 3,726 $56,858
LAUR Laureate Education Inc. Common Stock $31.24 1,807 $56,450
WVE Wave Life Sciences Ltd. Ordinary Shares $7.32 7,705 $56,400
WDAY Workday, Inc. $126.96 444 $56,370
Sum $581,161

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@alin
@John Fourier
@Andy Yeh Alpha
@Chanel Holden

Blog+More

State, society, and the narrow corridor to liberty

Joseph Corr

2023-09-28 08:26:00 Thursday ET

State, society, and the narrow corridor to liberty

Daron Acemoglu and James Robinson show a constant economic tussle between society and the state in the hot pursuit of liberty. Daron Acemoglu and James R

+See More

AYA Analytica financial health memo (FHM) blog post and podcast content curation with wise words of wisdom

Daisy Harvey

2019-04-30 07:15:00 Tuesday ET

AYA Analytica financial health memo (FHM) blog post and podcast content curation with wise words of wisdom

Through our AYA fintech network platform, we share numerous insightful posts on personal finance, stock investment, and wealth management. Our AYA finte

+See More

Nobel Laureate Joseph Stiglitz maintains that globalization only works for a few elite groups.

Becky Berkman

2019-08-09 18:35:00 Friday ET

Nobel Laureate Joseph Stiglitz maintains that globalization only works for a few elite groups.

Nobel Laureate Joseph Stiglitz maintains that globalization only works for a few elite groups; whereas, the government should now reassert itself in terms o

+See More

Warren Buffett warns that the current cap ratio of U.S. stock market capitalization to real GDP seems to be much higher than the long-run average benchmark.

James Campbell

2019-08-24 14:38:00 Saturday ET

Warren Buffett warns that the current cap ratio of U.S. stock market capitalization to real GDP seems to be much higher than the long-run average benchmark.

Warren Buffett warns that the current cap ratio of U.S. stock market capitalization to real GDP seems to be much higher than the long-run average benchmark.

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More

Former New York Times team journalist and Pulitzer Prize winner Charles Duhigg delves into how we can change our lives for the better by mastering our habits from day to day.

Monica McNeil

2025-06-05 00:00:00 Thursday ET

Former New York Times team journalist and Pulitzer Prize winner Charles Duhigg delves into how we can change our lives for the better by mastering our habits from day to day.

Former New York Times team journalist and Pulitzer Prize winner Charles Duhigg describes, discusses, and delves into how we can change our respective lives

+See More